首页> 美国卫生研究院文献>IEEE Journal of Translational Engineering in Health and Medicine >The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection Diagnosis Monitoring and Treatment in Low- and Middle-Income Countries
【2h】

The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection Diagnosis Monitoring and Treatment in Low- and Middle-Income Countries

机译:美国国立卫生研究院负担得起的癌症技术计划:在中低收入国家/地区改善对癌症检测诊断监测和治疗的资源适当技术的获取途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Point-of-care (POC) technologies have proved valuable in cancer detection, diagnosis, monitoring, and treatment in the developed world, and have shown promise in low-and-middle-income countries (LMIC) as well. Despite this promise, the unique design constraints presented in low-resource settings, coupled with the variety of country-specific regulatory and institutional dynamics, have made it difficult for investigators to translate successful POC cancer interventions to the LMIC markets. In response to this need, the National Cancer Institute has partnered with the National Institute of Biomedical Imaging and Bioengineering to create the National Institutes of Health Affordable Cancer Technologies (ACTs) program. This program seeks to simplify the pathway to market by funding multidisciplinary investigative teams to adapt and validate the existing technologies for cancer detection, diagnosis, and treatment in LMIC settings. The various projects under ACTs range from microfluidic cancer diagnostic tools to novel treatment devices, each geared for successful clinical adaptation to LMIC settings. Via progression through this program, each POC innovation will be uniquely leveraged for successful clinical translation to LMICs in a way not before seen in this arena.
机译:即时医疗(POC)技术在发达国家已被证明对癌症的检测,诊断,监测和治疗具有重要价值,并且在中低收入国家(LMIC)也显示出了希望。尽管有这样的希望,但在资源匮乏的环境中出现的独特设计限制,加上特定国家/地区的监管和机构动态,使调查人员难以将成功的POC癌症干预措施转化为LMIC市场。为了满足这一需求,美国国家癌症研究所与美国国家生物医学成像和生物工程研究所合作,共同创建了美国国家卫生研究院负担得起的癌症技术(ACTs)计划。该计划旨在通过资助多学科的研究团队来适应和验证LMIC环境中用于癌症检测,诊断和治疗的现有技术,从而简化进入市场的途径。 ACTs下的各种项目,从微流控癌诊断工具到新型治疗设备,均适用于成功地临床适应LMIC设置。通过该计划的进展,将以独特的方式利用POC的每项创新,以成功的方式将其成功地转换为LMIC,这在本领域中是前所未有的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号